Closing Bell: Nervgen Pharma Corp down on Friday (NGEN)

Today, Nervgen Pharma Corp shares opened at $2.85 and closed at $2.85. It traded at a low of $2.83 to a high of $2.87.

Shares slipped -0.52 percent from the previous day's close of $2.87.

Today across North America, the TSX Composite closed 0.91% at 22814.81, the S&P 500 closed -0.51% at 5399.22, the Dow Jones Industrial Average closed 0.20% at 39935.07 and the Nasdaq Composite closed -0.93% at 17181.72.

Nervgen Pharma Corp has listed on the Toronto Venture Exchange (TSX-V) under the ticker NGEN.

A total of 46,800 shares was traded during the session, with total trades of 28. On average, Nervgen Pharma Corp has traded 59,758 shares in the last five days and 87,492 year-to-date.

The TSX-V overall saw 3,857 price advancers against 1,325 declines and 128 unchanged.

During the prior 52 weeks, NGEN.VN has traded as high as $3.98 (February 05,2024) and low as $1.58 (December 14,2023). Moreover, the shares have boosted 73.03% in the last year, while they have advanced 5.74% this year.

Following today's trading, Nervgen Pharma Corp has a market capitalization of $200.69 million on a float of 69,928 shares outstanding. Its annual EPS is $-0.34.

Nervgen Pharma Corp is a TSX Biotechnology company headquartered in Vancouver, CAN.

Nervgen Pharma Corp is holding an average recommendation of "Strong Sell" from 0.00 analysts according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..